Advanced Inhalation Therapies Ltd. (AIT) has announced the completion of a successful financing round, in which it has raised $1.25 million. AIT is developing nitric oxide based treatments for infectious lung diseases. The company says the funds will be used for two clinical trials.
Related posts
A Promising Treatment For Trauma-Induced Fibromyalgia
March 23, 2023
Generative AI Startup Helps Developers Test Code Logic
March 23, 2023
Cream Cheese And Cheddar Cheese – Made From Chickpeas
March 22, 2023
$8M For Startup That Digitizes The Construction Supply Chain
March 22, 2023
Facebook comments